DSM's pharma business reported net sales growth of 1%. However the company said the results were adversely impacted by an uneven delivery pattern at DSM Pharmaceutical Products and by lower margins at DSM Sinochem Pharmaceutical, despite higher volumes. DSM also said it expected business conditions in pharma to remain challenging for the remainder of the year.
DSM
Wednesday 14 November 2012
Pharma sales flat for DSM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment